Feng, Meizhen <br/><br/>
In vitro resistance selection with doravirine (MK-1439), a novel nonnucleoside reverse transcriptase inhibitor with distinct mutation development pathways.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Jan 2015 
 - 590-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.04201-14  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-HIV Agents--pharmacology<br/>Drug Resistance, Viral--drug effects<br/>HEK293 Cells--drug effects<br/>HIV-1--drug effects<br/>Humans<br/>Mutation<br/>Nitriles<br/>Pyridazines--pharmacology<br/>Pyridones--pharmacology<br/>Pyrimidines<br/>Reverse Transcriptase Inhibitors--pharmacology<br/>Rilpivirine--pharmacology<br/>Selection, Genetic<br/>Triazoles--pharmacology